Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives

Posted on by

Journal of Pharmaceutical Policy and Practice
https://joppp.biomedcentral.com/
[Accessed 02 Apr 2022]

 

Assessing public knowledge, attitudes and determinants of third COVID-19 vaccine booster dose acceptance: current scenario and future perspectives
People with weakened immune systems may not develop adequate protection after taking two doses of the mRNA-combined COVID-19 vaccine. The additional dose may improve the level of protection against Covid-19.
Authors: Ammar Abdulrahman Jairoun, Sabaa Saleh Al-Hemyari, Faris El-Dahiyat, Maimona Jairoun, Moyad Shahwan, Mena Al Ani, Mustafa Habeb and Zaheer-Ud-Din Babar
Citation: Journal of Pharmaceutical Policy and Practice 2022 15:26
Content type: Research Published on: 28 March 2022